Contact Us
Who Uses AdComplyRx?
We're Hiring!
Chrome Extension
Brands
Agencies
News
POV & Merch
Home
Login

MyAdComplyRx - Pharma SEM Regulatory & Brand Safety

Contact Us
Who Uses AdComplyRx?
We're Hiring!
Chrome Extension
Brands
Agencies
News
POV & Merch
Home
Login
  • Pharma Paid Search (SEM) FDA Warning Letters
  • Pharma Brand Safety for Search (SEM) - FDA Warning Letters Specific to Paid Search
  • FDA Warning Letters for Paid Search Engine Marketing (SEM)/PPC
  • New Page

FDA Warning Letters Specific to Paid Search (SEM) Sponsored Links - Part 1

Bayer Healthcare Pharma

LEVITRA® (vardenafil HCl) Tablets - FDA Warning Letter Specific to Paid Search Text Ads (SEM)

YAZ® (drospirenone and ethinyl estradiol) Tablets - FDA Warning Letter Specific to Paid Search Text Ads (SEM)

Mirena® (levonorgestrel-releasing intrauterine system) - FDA Warning Letter Specific to Paid Search Text Ads (SEM)


Biogen

TYSABRI (natalizumab) injection for intravenous use - FDA Warning Letter Specific to Paid Search Text Ads (SEM)


Boeringer Ingelheim

Spiriva® HandiHaler® (tiotropium bromide inhalation powder) - FDA Warning Letter Specific to Paid Search Text Ads (SEM)

Flomax® (tamsulosin hydrochloride) Capsules - FDA Warning Letter Specific to Paid Search Text Ads (SEM)

Mirapex® (pramipexole dihydrochloride) Tablets - FDA Warning Letter Specific to Paid Search Text Ads (SEM)

Pharma Brand Safety for Search (SEM) - FDA Warning Letters Specific to Paid Search

List and links to FDA Warning Letters specific to paid search (SEM) campaigns.

Back to Top
Privacy Policy
Submit New Brands & Keywords
Trends
Conferences
FDA BadAd Course
FDA Guidance
FDA Warning Letters
Competitive Advantage
Contact Us
AdComply, Inc., 33 Irving Place, New York, NY, 10003786-208-9440steven@adcomplyrx.com

Powered by Squarespace